{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:18:28Z","timestamp":1785417508050,"version":"3.56.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["surgpath.theclinics.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.path.2024.12.004","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:33:40Z","timestamp":1738280020000},"page":"359-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer Predisposition Syndromes Associated with Most Common Pediatric Solid Tumors"],"prefix":"10.1016","volume":"18","author":[{"given":"Jennifer C.","family":"Scull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Lopez-Terrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.path.2024.12.004_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S2352-4642(20)30275-3","article-title":"Predisposition to cancer in children and adolescents","volume":"5","author":"Kratz","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.path.2024.12.004_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s43018-021-00172-1","article-title":"Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors","volume":"2","author":"Fiala","year":"2021","journal-title":"Nat Cancer"},{"issue":"11","key":"10.1016\/j.path.2024.12.004_bib3","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1158\/1078-0432.CCR-23-4033","article-title":"Update on cancer predisposition syndromes and surveillance guidelines for childhood brain tumors","volume":"30","author":"Hansford","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.path.2024.12.004_bib4","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1158\/1078-0432.CCR-17-0834","article-title":"Genetic counselor recommendations for cancer predisposition evaluation and surveillance in the pediatric oncology patient","volume":"23","author":"Druker","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2024.12.004_bib5","article-title":"Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants","volume":"5","author":"de Andrade","year":"2024","journal-title":"HGG Adv"},{"issue":"3","key":"10.1016\/j.path.2024.12.004_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.path.2024.12.004_bib7","series-title":"GeneReviews((R))","article-title":"Li-fraumeni syndrome","author":"Schneider","year":"1993"},{"issue":"9","key":"10.1016\/j.path.2024.12.004_bib8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/humu.23035","article-title":"TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data","volume":"37","author":"Bouaoun","year":"2016","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.path.2024.12.004_bib9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/pbc.23349","article-title":"Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010","volume":"58","author":"Gozali","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.path.2024.12.004_bib10","series-title":"WHO classification of tumours: paediatric tumours","first-page":"1005","article-title":"Li-Fraumeni syndrome","author":"Lax","year":"2022"},{"issue":"1\u20132","key":"10.1016\/j.path.2024.12.004_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","article-title":"Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations","volume":"148","author":"Rausch","year":"2012","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.path.2024.12.004_bib12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/neuonc\/noad114","article-title":"Clinical outcome of pediatric medullobslastoma patients with Li-Fraumeni syndrome","volume":"25","author":"Kolodziejczak","year":"2023","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.path.2024.12.004_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","article-title":"Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort","volume":"19","author":"Waszak","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.path.2024.12.004_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.554388","article-title":"Clinical, genetic, and prognostic features of adrenocortical tumors in children: a 10-year single-center experience","volume":"10","author":"Miele","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.path.2024.12.004_bib15","first-page":"149","article-title":"Diseases predisposing to adrenocortical malignancy (Li-Fraumeni syndrome, beckwith-wiedemann syndrome, and carney complex)","volume":"111","author":"Jouinot","year":"2019","journal-title":"Exp Suppl"},{"issue":"8","key":"10.1016\/j.path.2024.12.004_bib16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10552-015-0607-3","article-title":"Bone cancer incidence by morphological subtype: a global assessment","volume":"26","author":"Valery","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.path.2024.12.004_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1415636","article-title":"Characterization of sarcoma topography in Li-Fraumeni syndrome","volume":"14","author":"Brockman","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.path.2024.12.004_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.celrep.2014.03.003","article-title":"Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma","volume":"7","author":"Chen","year":"2014","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.path.2024.12.004_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jmedgenet-2018-105664","article-title":"Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy","volume":"56","author":"Suerink","year":"2019","journal-title":"J Med Genet"},{"issue":"7","key":"10.1016\/j.path.2024.12.004_bib20","first-page":"1645","article-title":"Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients","volume":"54","author":"Aaltonen","year":"1994","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.path.2024.12.004_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","article-title":"Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD)","volume":"51","author":"Wimmer","year":"2014","journal-title":"J Med Genet"},{"issue":"11","key":"10.1016\/j.path.2024.12.004_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/jmedgenet-2015-103299","article-title":"Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort","volume":"52","author":"Lavoine","year":"2015","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.path.2024.12.004_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1470-2045(24)00026-3","article-title":"Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study","volume":"25","author":"Ercan","year":"2024","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.path.2024.12.004_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng.3202","article-title":"Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers","volume":"47","author":"Shlien","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.path.2024.12.004_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cge.12349","article-title":"Epigenetic mechanisms in the pathogenesis of Lynch syndrome","volume":"85","author":"Peltomaki","year":"2014","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.path.2024.12.004_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ng1294-405","article-title":"Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer","volume":"8","author":"Hemminki","year":"1994","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.path.2024.12.004_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.20863","article-title":"Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer","volume":"116","author":"Mangold","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.path.2024.12.004_bib32","first-page":"697","volume":"vol. 7","author":"Vujanic","year":"2022"},{"issue":"1","key":"10.1016\/j.path.2024.12.004_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41591-021-01581-6","article-title":"Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency","volume":"28","author":"Das","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.path.2024.12.004_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cell.2017.09.048","article-title":"Comprehensive analysis of hypermutation in human cancer","volume":"171","author":"Campbell","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.path.2024.12.004_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpedsurg.2021.08.008","article-title":"Pediatric solid tumors and associated cancer predisposition syndromes: workup, management, and surveillance. A summary from the APSA Cancer Committee","volume":"57","author":"Grant","year":"2022","journal-title":"J Pediatr Surg"},{"issue":"R2","key":"10.1016\/j.path.2024.12.004_bib31","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1093\/hmg\/ddaa091","article-title":"Recent advances in Wilms' tumor predisposition","volume":"29","author":"Maciaszek","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.path.2024.12.004_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/PAP.0000000000000017","article-title":"Wilms tumor: an update","volume":"21","author":"Al-Hussain","year":"2014","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.path.2024.12.004_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41585-023-00824-0","article-title":"Hallmark discoveries in the biology of Wilms tumour","volume":"21","author":"Perotti","year":"2024","journal-title":"Nat Rev Urol"},{"issue":"Suppl 2","key":"10.1016\/j.path.2024.12.004_bib35","article-title":"The pathophysiology of bilateral and multifocal Wilms tumors: what we can learn from the study of predisposition syndromes","volume":"70","author":"Welter","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.path.2024.12.004_bib36","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1152\/ajprenal.00248.2023","article-title":"Wilms' tumor gene 1: lessons from the interface between kidney development and cancer","volume":"326","author":"Torban","year":"2024","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"10.1016\/j.path.2024.12.004_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jmg.2006.041723","article-title":"Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour","volume":"43","author":"Scott","year":"2006","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.path.2024.12.004_bib38","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/jcp.26021","article-title":"The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis","volume":"233","author":"Bahrami","year":"2018","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.path.2024.12.004_bib39","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.21037\/tau.2020.03.27","article-title":"Syndromic Wilms tumor: a review of predisposing conditions, surveillance and treatment","volume":"9","author":"Liu","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"4","key":"10.1016\/j.path.2024.12.004_bib40","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1542\/peds.2004-0467","article-title":"WAGR syndrome: a clinical review of 54 cases","volume":"116","author":"Fischbach","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.path.2024.12.004_bib41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/jmg.31.6.471","article-title":"The Denys-Drash syndrome","volume":"31","author":"Mueller","year":"1994","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.path.2024.12.004_bib42","first-page":"84","article-title":"WT1 exon 1 deletion\/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences","volume":"56","author":"Huff","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.path.2024.12.004_bib43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ng1297-467","article-title":"Donor splice-site mutations in WT1 are responsible for Frasier syndrome","volume":"17","author":"Barbaux","year":"1997","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.path.2024.12.004_bib44","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/ajmg.a.32315","article-title":"Clinical and genetic heterogeneity in patients with mosaic variegated aneuploidy: delineation of clinical subtypes","volume":"146A","author":"Garcia-Castillo","year":"2008","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.path.2024.12.004_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"Reid","year":"2007","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.path.2024.12.004_bib46","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/ajmg.a.37801","article-title":"Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups","volume":"170","author":"Maas","year":"2016","journal-title":"Am J Med Genet"},{"issue":"13","key":"10.1016\/j.path.2024.12.004_bib47","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1158\/1078-0432.CCR-17-0710","article-title":"Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma","volume":"23","author":"Kalish","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.path.2024.12.004_bib48","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/ajmg.a.40374","article-title":"Health supervision for people with Bloom syndrome","volume":"176","author":"Cunniff","year":"2018","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.path.2024.12.004_bib49","first-page":"944","article-title":"Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31","volume":"56","author":"Szabo","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.path.2024.12.004_bib50","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/humu.21600","article-title":"Extending the phenotypes associated with DICER1 mutations","volume":"32","author":"Foulkes","year":"2011","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.path.2024.12.004_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-4608(93)90166-J","article-title":"Wilms' tumor in the Li-Fraumeni cancer family syndrome","volume":"67","author":"Hartley","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"10.1016\/j.path.2024.12.004_bib76","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmg.2017.12.010","article-title":"Identification of a novel CTR9 germline mutation in a family with Wilms tumor","volume":"61","author":"Martins","year":"2018","journal-title":"Eur J Med Genet"},{"issue":"12","key":"10.1016\/j.path.2024.12.004_bib52","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/ng.3440","article-title":"Mutations in the transcriptional repressor REST predispose to Wilms tumor","volume":"47","author":"Mahamdallie","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.path.2024.12.004_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007399","article-title":"Germline mutations and somatic inactivation of TRIM28 in Wilms tumour","volume":"14","author":"Halliday","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.path.2024.12.004_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2021.05.014","article-title":"Wilms tumour surveillance in at-risk children: literature review and recommendations from the SIOP-europe host genome working group and SIOP renal tumour study group","volume":"153","author":"Hol","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.path.2024.12.004_bib55","series-title":"GeneReviews((R))","article-title":"APC-associated polyposis conditions","author":"Yen","year":"1993"},{"issue":"6","key":"10.1016\/j.path.2024.12.004_bib56","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jso.24699","article-title":"Comparison of sporadic and FAP-associated desmoid-type fibromatoses","volume":"116","author":"Koskenvuo","year":"2017","journal-title":"J Surg Oncol"},{"issue":"7","key":"10.1016\/j.path.2024.12.004_bib57","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.21873\/anticanres.11702","article-title":"Desmoid tumors in familial adenomatous polyposis","volume":"37","author":"ML","year":"2017","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.path.2024.12.004_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079639","article-title":"Findings from the Peutz-Jeghers syndrome registry of Uruguay","volume":"8","author":"Tchekmedyian","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.path.2024.12.004_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030473","article-title":"The management of peutz-jeghers syndrome: European hereditary tumour group (EHTG) guideline","volume":"10","author":"Wagner","year":"2021","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.path.2024.12.004_bib60","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","article-title":"Frequency and spectrum of cancers in the Peutz-Jeghers syndrome","volume":"12","author":"Hearle","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2024.12.004_bib61","series-title":"WHO classification of tumours series","first-page":"35","article-title":"WHO classification of tumours: paediatric tumours","author":"Reyes-Mugica","year":"2022"},{"issue":"6","key":"10.1016\/j.path.2024.12.004_bib62","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s13311-022-01277-w","article-title":"Nervous system (NS) tumors in cancer predisposition syndromes","volume":"19","author":"Patil","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.path.2024.12.004_bib63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/neuonc\/noz154","article-title":"Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas","volume":"22","author":"Surun","year":"2020","journal-title":"Neuro Oncol"},{"issue":"36","key":"10.1016\/j.path.2024.12.004_bib64","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2014.58.2569","article-title":"Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations","volume":"32","author":"Smith","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.path.2024.12.004_bib65","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10689-023-00330-7","article-title":"Perspectives on the implications of carrying putative pathogenic variants in the medulloblastoma predisposition genes ELP1 and GPR161","volume":"22","author":"Smith","year":"2023","journal-title":"Fam Cancer"},{"issue":"4","key":"10.1016\/j.path.2024.12.004_bib66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10689-021-00229-1","article-title":"Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE host genome working group","volume":"20","author":"Fruhwald","year":"2021","journal-title":"Fam Cancer"},{"issue":"3","key":"10.1016\/j.path.2024.12.004_bib67","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejmg.2010.12.007","article-title":"Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid\/rhabdoid tumour","volume":"54","author":"Beddow","year":"2011","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.path.2024.12.004_bib68","series-title":"Neuroblastoma","first-page":"356","author":"Shimada","year":"2022"},{"issue":"15","key":"10.1016\/j.path.2024.12.004_bib69","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/1078-0432.CCR-24-0237","article-title":"Neuroblastoma predisposition and surveillance-an update from the 2023 AACR childhood cancer predisposition workshop","volume":"30","author":"Kamihara","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"7215","key":"10.1016\/j.path.2024.12.004_bib70","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature07397","article-title":"Activating mutations in ALK provide a therapeutic target in neuroblastoma","volume":"455","author":"George","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.path.2024.12.004_bib71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/383253","article-title":"Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma","volume":"74","author":"Trochet","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"7215","key":"10.1016\/j.path.2024.12.004_bib72","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of ALK as a major familial neuroblastoma predisposition gene","volume":"455","author":"Mosse","year":"2008","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.path.2024.12.004_bib73","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/sj.onc.1208532","article-title":"PHOX2B mutations and genetic predisposition to neuroblastoma","volume":"24","author":"Perri","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.path.2024.12.004_bib74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/2159-8290.CD-21-1094","article-title":"A summary of the Inaugural WHO Classification of pediatric tumors: transitioning from the optical into the molecular era","volume":"12","author":"Pfister","year":"2022","journal-title":"Cancer Discov"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:36:49Z","timestamp":1747928209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918124000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1875918124000977"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2024.12.004","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer Predisposition Syndromes Associated with Most Common Pediatric Solid Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}